News
- New WHO report on alcohol pricing: Europe ignores cost-effective ways to lower health risks
- FDA Approves First-Line Immunotherapy for Patients with MSI-H/dMMR Metastatic Colorectal Cancer
- WHO/Europe, EU deliver critical supplies to COVID-19 frontline
- PAHO/WHO Trinidad and Tobago Country Office supports the Ministry of Health’s capacity for testing, collection, and processing of clinical and epidemiological data for COVID-19
- Building on Ebola response to tackle COVID-19 in DRC
- Digital health is about empowering people
- Five questions to ask your health professional before you get a medical implant
- New Accessible Transportation for Persons with Disabilities Regulations now in force
- First COVID-19 treatment recommended for EU authorisation
- Global regulators discuss data requirements for phase 3 trials of COVID-19 vaccines
- NIH investigators hope CD47 study leads to broad-spectrum infectious diseases immunotherapy
- HHS Announces Partnership with Morehouse School of Medicine to Fight COVID-19 in Racial and Ethnic Minority and Vulnerable Communities
- The Department of National Defence releases 2019 report on suicide mortality
- Backgrounder - Canada’s support for sexual and reproductive health and rights
- Academia developing medicines for rare diseases to receive free EMA scientific advice
- Africa’s wild polio-free status to be determined in August
- Tapping into WHO expertise allows Uzbekistan to increase COVID-19 testing
- Brain inflammation linked to uncommon type of 'early-onset' dementia
- International regulators stress value of safe and effective vaccines
- Coronavirus (COVID-19) Update: FDA Issues Warning Letters to Companies Inappropriately Marketing Antibody Tests, Potentially Placing Public Health at Risk
- Countries failing to prevent violence against children, agencies warn
- Counterfeit Cialis 20mg tablets pose a serious risk to your health and should not be taken
- WHO welcomes preliminary results about dexamethasone use in treating critically ill COVID-19 patients
- FDA Approves First Treatment for Adult Onset Still’s Disease, a Severe and Rare Disease
- Proposed delayed commencement of certain medical device regulatory changes
Clinical Research News
Próximos ensayos clínicos
-
Ramsay Générale de SantéReclutamientoEstrés | Tendinopatía del manguito rotadorFrancia
-
Haisco Pharmaceutical Group Co., Ltd.Aún no reclutandoEPOC (Enfermedad Pulmonar Obstructiva Crónica)Porcelana
-
Shanghai Helioson Pharmaceutical Co., Ltd.Aún no reclutandoLinfoma no Hodgkin de células BPorcelana
-
Medical University of South CarolinaNational Institutes of Health (NIH); National Institute on Deafness and Other...Aún no reclutandoSaludable | Olfato
-
Helwan UniversityAún no reclutandoInfección del Sitio Quirúrgico (ISQ)
-
University of California, San DiegoUniversity of Texas Southwestern Medical CenterAún no reclutandoTrastorno esquizoafectivo | SchizopheniaEstados Unidos
-
Novo Nordisk A/SAún no reclutando
-
Southwest Hospital, ChinaAún no reclutandoEnfermedad de alzheimerPorcelana
-
Fujian Provincial HospitalAún no reclutandoTrastornos cognitivos | EnvejecidoPorcelana
-
Zai Lab (Shanghai) Co., Ltd.Aún no reclutandoVoluntarios SaludablesNueva Zelanda
-
Shanghai Ark Biopharmaceutical Co., Ltd.ReclutamientoInfecciones por virus respiratorio sincitialPorcelana
-
BrightGene Bio-Medical Technology Co., Ltd.Aún no reclutandoOverweight or Obese Participants Without DiabetesPorcelana
